What is immunohistochemistry (IHC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immunohistochemistry (IHC): Definition and Applications

Immunohistochemistry (IHC) is a powerful laboratory technique that uses antibody-antigen interactions to detect and localize specific proteins in tissue sections, allowing visualization of cellular components within the context of intact tissue architecture.

Basic Principles of IHC

Immunohistochemistry works through the following mechanism:

  • It exploits the specific binding between antibodies and their target antigens in tissue sections
  • The bound antibody-antigen complex is visualized using detection systems (enzymatic or fluorescent labels)
  • Results are typically examined with light microscopy (for chromogenic IHC) or fluorescence microscopy (for immunofluorescence)

Types of IHC Methods

Chromogenic IHC

  • Uses enzymatic labels such as peroxidase or alkaline phosphatase
  • Produces a colored precipitate visible under standard light microscopy
  • Common chromogens include DAB (3'-diaminobenzidine), which produces a brown color

Immunofluorescence (IF)

  • Uses fluorescent dyes conjugated to antibodies
  • Requires fluorescence microscopy for visualization
  • Allows for better multiplexing capabilities

Multiplex IHC/IF Techniques

Recent advances have led to multiplex IHC/IF methods that allow simultaneous detection of multiple markers:

  • Traditional multiplex IHC: Uses multiple chromogens with different colors
  • Multiplex immunofluorescence (mIF): Uses different fluorophores with distinct emission spectra
  • Sequential staining methods: Multiple rounds of staining, imaging, and signal removal
  • Combined markers: Novel approaches using dual or triple markers on a single slide 1

These multiplex techniques provide several advantages:

  • Characterization of complex immunophenotypes
  • Assessment of spatial relationships between multiple cell types
  • Quantification of immune cell subsets
  • Preservation of tissue for additional testing 1

Clinical and Research Applications

IHC has become an essential tool in both clinical diagnostics and research:

Diagnostic Applications

  • Classification of neoplasms and determination of tumor origin
  • Detection of small tumor foci not visible on routine H&E staining
  • Identification of specific cell types and their distribution 2

Prognostic and Predictive Applications

  • Assessment of biomarkers like HER2 in breast cancer
  • Identification of therapeutic targets (e.g., PD-L1, CD19, CD30)
  • Surrogate markers for molecular alterations 2, 3

Research Applications

  • Investigation of early changes in transformed tissues
  • Differentiation between hyperplasia and neoplasia
  • Spatial analysis of the tumor microenvironment 4

Technical Considerations

The reliability of IHC results depends on several factors:

Pre-analytical Variables

  • Tissue fixation method and duration
  • Slide storage (antigenicity can decrease by 50% after just 2 weeks) 1
  • Antigen retrieval techniques

Analytical Variables

  • Antibody specificity and validation
  • Detection systems
  • Staining protocols

Post-analytical Variables

  • Interpretation methods (visual vs. digital)
  • Scoring systems
  • Quality control measures 1

Advanced IHC Analysis

Modern IHC analysis increasingly incorporates:

  • Digital image acquisition and analysis
  • Color deconvolution and spectral unmixing for multiplex assays
  • Quantitative assessment of marker expression
  • Spatial relationship analysis between different cell types 1

Limitations and Challenges

Despite its utility, IHC has several limitations:

  • Subjectivity in interpretation
  • Variability in staining intensity
  • Cross-reactivity with other tissue types
  • Limited multiplexing capability in traditional IHC 1

Future Directions

The field is evolving toward:

  • Higher multiplexing capabilities
  • Integration with other -omics technologies
  • Artificial intelligence-assisted interpretation
  • Standardized protocols for better reproducibility 1, 5

IHC remains a cornerstone technique in pathology, continually evolving to meet the demands of precision medicine and advanced biomarker analysis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An Introduction to the Performance of Immunohistochemistry.

Methods in molecular biology (Clifton, N.J.), 2019

Research

Comprehensive Immunohistochemistry: Digital, Analytical and Integrated.

Pathobiology : journal of immunopathology, molecular and cellular biology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.